Neurocognitive function of children treated for high-risk B-acute lymphoblastic leukemia (HR-ALL) randomized to Capizzi (CMTX) versus high-dose methotrexate (HDMTX): A report from the Children’s Oncology Group (COG).
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: The University of Texas Southwestern Medical Center, The University of Texas at San Antonio Health Science Center, Children's National, University of Florida, University of Miami, Sylvester Comprehensive Cancer Center, Children's Hospital of Philadelphia, NYU Langone Health, University of Utah, University of California, San Francisco, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598817895
